Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

Manhattan Named a Leader in 2025 Gartner® Magic Quadrant™ for Transportation Management Systems for the Seventh Consecutive Year

SYDNEY, April 10, 2025 /PRNewswire/ -- Manhattan Associates Inc. (NASDAQ: MANH), a global leader in supply chain commerce solutions, announced today that it has been named...

VIVOS Advises on Sale of The Providore Singapore to F&B Industry Veterans

SINGAPORE, April 10, 2025 /PRNewswire/ -- Singapore business advisory firm VIVOS Pte. Ltd. is pleased to announce the successful completion of the sale and...

Important Notice Regarding the Upgrade of Visionary Holdings Inc.’s Website and Email System

TORONTO, April 10, 2025 /PRNewswire/ --  To All Employees, Partners, and Customers: Due to a recent malicious IT attack on our company,...